Skip to content

Small number of individuals with drug-resistant HIV having unprotected sex

Warning issued over bleeding within the skull in patients taking tipranavir

Modelling study predicts efficacy and cost-effectiveness of HIV treatment after single-dose nevirapine

AmfAR funds 'bold' viral eradication studies

Kaletra receives EU marketing approval; developing countries registration 'moving forward'

2005 decline in UK's sexual health 'disappointing'

Zimbabwe observes a reduction in HIV prevalence, but why?

California court says people with HIV can be sued for passing virus, even if untested

FDA approves first three-drug fixed-dose tablet for PEPFAR use

15th HIV Resistance Workshop: does low-level resistance matter?

15th HIV Resistance Workshop: resistance to Kaletra monotherapy

15th HIV Resistance Workshop: resistance to integrase inhibitors

15th HIV Resistance Workshop: burden of infectious drug-resistant HIV may be falling

15th HIV Resistance Workshop: new NRTIs

15th HIV Resistance Workshop: tenofovir resistance in Africans may be quicker, more frequent

15th HIV Resistance Workshop: can new Tibotec NNRTI overcome cross-class resistance?

Take home messages from the 15th HIV Resistance Workshop

Monthly sulfadoxine-pyrimethamine might protect HIV-positive African pregnant women against placental malaria